Holen Sie sich die Stockscreener-App
0.3286
8.31%
0.0252
Handel nachbörslich:
.32
-0.0086
-2.62%
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka
Mag Mile Capital (OTCQB: MMCP) Surges 365% as CRE Financing Pipeline Expands Across Key Sectors - marketscreener.com
Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - MEXC
Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - MEXC
Mangoceuticals Inc (MGRX) Stock Price, Quote, News & History - Benzinga
Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga
Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks
Setup Watch: Is Mangoceuticals Inc a good ESG investmentShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Layoff Watch: Can Mangoceuticals Inc ride the EV waveWeekly Investment Recap & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan
Mangoceuticals (MGRX) reprices CEO Jacob Cohen stock options to $0.45 - Stock Titan
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mangoceuticals files $73 million lawsuit against tech vendor By Investing.com - Investing.com South Africa
Mangoceuticals files civil lawsuit against Clarity Ventures - TipRanks
Mangoceuticals Files $73 Million Lawsuit Against Clarity Ventures Over Alleged Contract Breach - geneonline.com
Mangoceuticals Sues Former Tech Partner Over Platform Dispute - TipRanks
Mangoceuticals announces lawsuit seeking damages exceeding $73 million against Clarity Ventures - marketscreener.com
Mangoceuticals files $73 million lawsuit against tech vendor - Investing.com
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures - TradingView
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - The Manila Times
Jacob Cohen option repricing at Mango - TradingView
Mangoceuticals (NASDAQ: MGRX) reprices CEO options and pursues $73M Clarity lawsuit - Stock Titan
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding - GlobeNewswire
Mangoceuticals plunges after denying Lilly, Novo partnerships - MSN
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders - MSN
Mangoceuticals stock surges on early success of subscription TRT model - MSN
Merger Talk: Is Mangoceuticals Inc stock a top performer YTD2026 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Breakouts: Can Mangoceuticals Inc ride the EV wave2026 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI
Mangoceuticals, Cube Group partner for up to $100M Solana-focused DAT strategy - MSN
Analyst Downgrade: Can Mangoceuticals Inc expand into new marketsEarnings Recap Report & Reliable Volume Spike Alerts - baoquankhu1.vn
Mangoceuticals, Inc. Files International Patent Application for Innovative Antiviral Feed Additive Technology MGX-0024 - Quiver Quantitative
Mangoceuticals, Inc. announces percent patent filing for MGX-0024 antiviral technology to include inhibiting respiratory or orally acquired virus infection in animals or birds - marketscreener.com
Mangoceuticals, Inc. Announces Pct Patent Filing for Mgx-0024 Antiviral Technology - marketscreener.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan
Mangoceuticals' MGX-0024 Achieves 100% Survival in 29,000-Bird Studies—A Turning Point for Biosecurity? - Bitget
MGRX Earnings History & Surprises | EPS & Revenue Results | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
Aug Closing: Is Mangoceuticals Inc a momentum stockJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
MGRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Institution Moves: Can Mangoceuticals Inc deliver consistent dividendsWeekly Stock Analysis & Community Consensus Trade Signals - baoquankhu1.vn
MGRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MGRXMangoceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
MGRX Should I Buy - Intellectia AI
Can Mangoceuticals Inc ride the EV waveJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Mangoceuticals reports data on antiviral compound for poultry By Investing.com - Investing.com India
Mangoceuticals' MGX-0024 achieves zero respiratory-related mortality, shows H5N1 prophylactic benefit - marketscreener.com
Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit - TradingView
Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data - TipRanks
Mangoceuticals reports data on antiviral compound for poultry - Investing.com
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study - The Manila Times
Mangoceuticals, Inc. Reports Promising Results for Antiviral Compound MGX-0024 in Poultry Respiratory Disease Management - Quiver Quantitative
Mangoceuticals (MGRX) reports zero respiratory deaths in 29,000 MGX-0024-treated birds - Stock Titan
Mangoceuticals’ Patented MGX-0024 Achieves Zero - GlobeNewswire
2.33%
5.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):